Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Immunogenicity of Different Influenza Vaccines in Patients With Hematologic Malignancies
NCT07485855Phase 3Recruiting
- Sponsor
- Asan Medical Center
- Start
- Dec 2025
- Primary completion
- Apr 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of trivalent inactivated influenza vaccine, influenza vaccine + MF59C.1 in influenza, sponsored by Asan Medical Center. Started Dec 2025; status: recruiting.
02
Drugs
trivalent inactivated influenza vaccineinfluenza vaccine + MF59C.1
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07485855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07485855.